The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex.
暂无分享,去创建一个
[1] A. Kimchi,et al. The paradox of autophagy and its implication in cancer etiology and therapy , 2009, Apoptosis.
[2] S. Pattingre,et al. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. , 2008, Molecular cell.
[3] J. Mendelsohn,et al. Requirement of hypoxia-inducible factor-1α down-regulation in mediating the antitumor activity of the anti–epidermal growth factor receptor monoclonal antibody cetuximab , 2008, Molecular Cancer Therapeutics.
[4] G. Semenza,et al. Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia* , 2008, Journal of Biological Chemistry.
[5] M. Jäättelä,et al. Autophagy: An emerging target for cancer therapy , 2008, Autophagy.
[6] Yongqiang Chen,et al. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3 , 2008, Autophagy.
[7] K. Liang,et al. Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1α , 2007, Molecular Cancer.
[8] G. Mills,et al. Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab. , 2007, Cancer research.
[9] Yosuke Kawamura,et al. Expression of Autophagy-Associated Genes in Skeletal Muscle: An Experimental Model of Chloroquine-Induced Myopathy , 2007, Pathobiology.
[10] R. Deberardinis,et al. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. , 2007, Genes & development.
[11] B. Oh,et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG , 2006, Nature Cell Biology.
[12] G. Mills,et al. Autophosphorylation of Akt at Threonine 72 and Serine 246 , 2006, Journal of Biological Chemistry.
[13] Sudeshna Dutta,et al. Autophagic programmed cell death by selective catalase degradation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[14] Yiling Lu,et al. Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells , 2006, Oncogene.
[15] Y. Kondo,et al. Autophagy and Cancer Therapy , 2006, Autophagy.
[16] B. Levine. Unraveling the Role of Autophagy in Cancer , 2006, Autophagy.
[17] Michael D. Schneider,et al. Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.
[18] Raymond Sawaya,et al. The role of autophagy in cancer development and response to therapy , 2005, Nature Reviews Cancer.
[19] G. Kroemer,et al. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death , 2005, Journal of Cell Science.
[20] J. Mendelsohn,et al. The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression , 2005, Oncogene.
[21] Eric H. Baehrecke,et al. Autophagy: dual roles in life and death? , 2005, Nature Reviews Molecular Cell Biology.
[22] G. Mills,et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. , 2005, Cancer research.
[23] Philippe Dessen,et al. Inhibition of Macroautophagy Triggers Apoptosis , 2005, Molecular and Cellular Biology.
[24] Daniel J. Klionsky,et al. Autophagy in Health and Disease: A Double-Edged Sword , 2004, Science.
[25] M. Jäättelä,et al. Multiple cell death pathways as regulators of tumour initiation and progression , 2004, Oncogene.
[26] A. Kimchi,et al. Autophagy as a cell death and tumor suppressor mechanism , 2004, Oncogene.
[27] Govind Bhagat,et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. , 2003, The Journal of clinical investigation.
[28] Arnold J. Levine,et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] Daniel J Klionsky,et al. A unified nomenclature for yeast autophagy-related genes. , 2003, Developmental cell.
[30] K Kian Ang,et al. The epidermal growth factor receptor mediates radioresistance. , 2003, International journal of radiation oncology, biology, physics.
[31] S. Israels,et al. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF , 2003, Oncogene.
[32] G. Semenza,et al. Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway* , 2002, The Journal of Biological Chemistry.
[33] M. Nakagawa,et al. The first molecular evidence that autophagy relates rimmed vacuole formation in chloroquine myopathy. , 2002, Journal of biochemistry.
[34] J. Mendelsohn,et al. Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody , 2001, Oncogene.
[35] S. Emr,et al. Autophagy as a regulated pathway of cellular degradation. , 2000, Science.
[36] Takeshi Noda,et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.
[37] J. Mendelsohn,et al. Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c- jun N-terminal kinase activity , 2000, British Journal of Cancer.
[38] G. Semenza,et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.
[39] D. Mottet,et al. ERK activation upon hypoxia: involvement in HIF‐1 activation , 2000, FEBS letters.
[40] H. Hibshoosh,et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.
[41] D L Pincus,et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. , 1999, Genomics.
[42] P. Carmeliet,et al. Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis (vol 394, pg 485, 1998) , 1998 .
[43] B. Shilo,et al. Insulin induces transcription of target genes through the hypoxia‐inducible factor HIF‐1α/ARNT , 1998, The EMBO journal.
[44] P. Carmeliet,et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.
[45] G. Semenza,et al. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. , 1997, Cancer research.
[46] G. Semenza,et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[47] N. Rosen,et al. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. , 1995, The Journal of clinical investigation.
[48] J. Baselga,et al. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts. , 1993, Cancer research.
[49] Hideo Masui,et al. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. , 1993, Cancer Research.
[50] G. Semenza,et al. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.
[51] Y. Ohsumi,et al. Autophagy in yeast: a TOR-mediated response to nutrient starvation. , 2004, Current topics in microbiology and immunology.